SHEMESH SHAY (Chief Development Officer) purchased 0.0% of their position (220.00 shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $1.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/27/2022ACC: 0001104659-22-103166
Officer· Chief Development Officer
Since Feb 2022
+220.00
Net shares
Net buyer
$1.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
220.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+220.00
Price / share
$7.87
Trade value
$1.73K
% of position
0.0%
9/23/2022
1.24M→1.25M
Total
Net shares
+220.00
Net value
$1.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2022 | P · Purchase | +220.00 | $7.87 | $1.73K | 0.0% | 1.24M | 1.25M |
| Total | +220.00 | $1.73K | ||||||
Derivative Transactions0
No derivative transactions reported